Medtronic Investor Handout September 2023

Medtronic's September 2023 investor handout outlines the company's strategy to deliver durable growth through mid-single digit organic revenue expansion, driven by high-growth medical technology markets and innovative products including the MiniMed 780G system and Hugo robotic-assisted surgery system. The document emphasizes disciplined capital allocation, portfolio optimization, and operational transformation aimed at improving financial performance and shareholder returns.